DOI: https://doi.org/10.22263/2312-4156.2021.5.23
Lazuko S.S.
2-ethylthiobenzimidazole hydrobromide prevents a decrease in coronary vascular tone and myocardial contractility in rats with experimental diabetes mellitus
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2021;20(5):23-33.
Abstract.
Objectives. To assess the possibility of preventing the disturbances of coronary vascular tone and myocardial contractile function caused by diabetes mellitus with the help of 2-ethylthiobenzimidazole hydrobromide.
Material and methods. Coronary vascular tone and myocardial contractile function were studied on preparations of rat hearts isolated by the Langendorff method. The iNOS blockade was carried out with S-methylisothiourea (S-MT, 10-6M). Diabetes mellitus in rats was modelled by means of a single intraperitoneal injection of streptozocin (50 mg / kg). 2-ethylthiobenzimidazole hydrobromide (2-ETG) was injected intraperitoneally at a dose of 3 mg / kg. The concentration of stable degradation products of NO (NO2-/NO3-), superoxide dismutase, catalase, diene conjugates and malondialdehyde in the left ventricular homogenate was determined by spectrophotometric method. The content of inducible and endothelial NO-synthases (eNOS), interleukin 1β, C-reactive protein in the blood serum of experimental animals was determined by enzyme immunoassay.
Results. In the hearts of «2-ETG + Diabetes mellitus» animal group no changes in the coronary perfusion pressure and developed intraventricular pressure were observed before and after the use of the highly selective iNOS blocker S-methylisothiourea. In the blood serum of these animals group, an increase in the concentration of eNOS was observed, against the background of a decrease in the accumulation of iNOS, a decrease in the concentration of lipid peroxidation products was determined against the background of an increase in the activity of the antioxidant system and a decrease of systemic inflammation.
Conclusions. Intraperitoneal injection of 2-ethylthiobenzimidazole hydrobromide prevents a decrease in coronary vascular tone and myocardial contractile function caused by hyperproduction of nitrogen monoxide of inducible NO-synthase in diabetes mellitus. This effect of 2-ethylthiobenzimidazole hydrobromide is associated with: limiting the formation of oxidative stress; limiting the nitrosative stress; the decrease in the concentration of inflammatory markers.
Key words: 2-ethylthiobenzimidazole hydrobromide, inducible NO-synthase, diabetes mellitus, coronary vascular tone.
References
1. Sun J, Druhan LJ, Zweier JL. Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch Biochem Biophys. 2010 Feb;494(2):130-7. doi: http://dx.doi.org/10.1016/j.abb.2009.11.019
2. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002 Apr;51(4):1076-82. doi: http://dx.doi.org/10.2337/diabetes.51.4.1076
3. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2144-52. doi: http://dx.doi.org/10.1152/ajpheart.00591.2005
4. Arora RK, Kaur N, Bansal Y, Bansal G. Novel coumarin-benzimidazole derivatives as antioxidants and safer anti-inflammatory agents. Acta Pharm Sin B. 2014 Oct;4(5):368-75. doi: http://dx.doi.org/10.1016/j.apsb.2014.07.001
5. Bakri YE, Anouar EH, Marmouzi I, Sayah K, Ramli Y, Faouzi MEA, et al. Potential antidiabetic activity and molecular docking studies of novel synthesized 3.6-dimethyl-5-oxo-pyrido[3,4-f][1,2,4]triazepino[2,3-a]benzimidazole and 10-amino-2-methyl-4-oxo pyrimido[1,2-a]benzimidazole derivatives. Mol Model. 2018 Jun;24(7):179. doi: http://dx.doi.org/10.1007/s00894-018-3705-9
6. Veremei IS, Solodkov AP, Deiun GV, Golman VI. Reduction of NO3 to NO2 by zinc dust in the presence of ammonia complex of copper sulfate. V: Viteb gos med un-t; Kosinets AN, red. 40 let farmatsevticheskomu fakul'tetu: sb nauch tr. Vitebsk, RB; 1999. Р. 274-6. (In Russ.)
7. Gavrilov VB, Gavrilova AR, Khmara NF. Measurement of diene conjugates in plasma by ultraviolet absorption of heptane and isopropyl extracts. Lab Delo. 1988;(2):60-4. (In Russ.)
8. Andreeva LI, Kozhemiakin VA. Modification of the method for the determination of lipid peroxides in the thiobarbituric acid test. Lab Delo. 1988;(1):41-3. (In Russ.)
9. Stalnoi MD, Garishvili TG. Method for determination of malonic aldehyde with thiobarbituric acid. V: Orekhovich VN, red. Sovremennye metody v biokhimii. Moscow, RF: Meditsina; 1977. Р. 66-8. (In Russ.)
10. Danchenko EO, Chirkin AA, Balaeva-Tikhomirova OM, Tolkacheva TA. Methods of biochemical research based on the use of specialized equipment: metod rekomendatsii dlia vypolneniia lab rabot. Vitebsk, RB: VGU im PM Masherova; 2018. 51 р. (In Russ.)
11. Babkov DA, Zhukowskaya ON, Borisov AV, Babkova VA, Sokolova EV, Brigadirova AA, et al. Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators. Bioorg Med Chem Lett. 2019 Sep;29(17):2443-2447. doi: http://dx.doi.org/10.1016/j.bmcl.2019.07.035
12. Lazuko SS, Beliaeva LE, Solodkov AP. Specific role of induced NO synthase in the mechanisms of regulation of coronary vascular tone in rats under immobilization stress developing against the background of diabetes mellitus. Ros Fiziol Zhurn im IM Sechenova. 2014;100(4):433-44. (In Russ.)
13. Zhu M, Chen J, Tan Z, Wang J. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells. Anesth Analg. 2012 Feb;114(2):303-9. doi: http://dx.doi.org/10.1213/ANE.0b013e31823f0c42
14. Lazuko SS. Mechanisms of cardiac vascular tone regulation: role of iNOS and potassium channels: monografiia. Vitebsk, RB: VGMU; 2019. 215 р. (In Russ.)
15. Zhang Z, Shi G, Liu Y, Xing H, Kabakov AY, Zhao AS, Agbortoko V. Coronary endothelial dysfunction prevented by small-conductance calcium-activated potassium channel activator in mice and patients with diabetes. J Thorac Cardiovasc Surg. 2020 Dec;160(6):e263-8. doi: http://dx.doi.org/10.1016/j.jtcvs.2020.01.078
16. Minhas R, Bansal Y. Inhibition of iNOS by Benzimidazole Derivatives: Synthesis, Docking, and Biological Evaluations. Med Chem. 2021 Sep. doi: http://dx.doi.org/10.2174/1573406417666210927123137
Information about authors:
Lazuko S.S. – Candidate of Biological Sciences, associate professor, head of the Chair of Normal Physiology, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Normal Physiology. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Svetlana S. Lazuko.
